Incyte Corporation Ransomware Attack
Ransomware victimRansomed
About this victim
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. You have been given clear instructions, reach out to us before it's too late.
Overview
View group profileIndustry
Manufacturing
Country
United States
Discovered
7 months ago
Attack date
Apr 22, 2026
Confidence
100%
Severity
Medium
Status
Claimed
Threat group
dragonforceTotal victims
382
First seen
Nov 2025
Last seen
Oct 2026
Threat level
2.4/10Status breakdown
Victim's position within group
Industry
Manufacturing
Known target sector
Country
United States
Not a listed target country
Other victims
View all (382)Same group · dragonforce
Group activity
Monthly attacks · dragonforce
382
total · avg 31.8/mo